Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Systems biology of cisplatin resistance: past, present and future.

Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G.

Cell Death Dis. 2014 May 29;5:e1257. doi: 10.1038/cddis.2013.428.

PMID:
24874729
[PubMed - in process]
Free PMC Article
2.

Genetic Interactions of STAT3 and Anticancer Drug Development.

Fang B.

Cancers (Basel). 2014 Mar 6;6(1):494-525. doi: 10.3390/cancers6010494.

PMID:
24662938
[PubMed]
Free PMC Article
3.

Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients.

Li W, Zhou F, Zhou C.

Onco Targets Ther. 2014 Feb 13;7:253-61. doi: 10.2147/OTT.S45096. eCollection 2014. Review.

PMID:
24611018
[PubMed]
Free PMC Article
4.

Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers.

Scheff RJ, Schneider BJ.

Semin Intervent Radiol. 2013 Jun;30(2):191-8. doi: 10.1055/s-0033-1342961. Review.

PMID:
24436536
[PubMed]
Free PMC Article
5.

Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review.

Jazieh AR, Al Sudairy R, Abu-Shraie N, Al Suwairi W, Ferwana M, Murad MH.

Ann Thorac Med. 2013 Oct;8(4):204-8. doi: 10.4103/1817-1737.118503.

PMID:
24250733
[PubMed]
Free PMC Article
6.

Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.

OuYang PY, Su Z, Mao YP, Deng W, Xie FY.

PLoS One. 2013 Nov 13;8(11):e79000. doi: 10.1371/journal.pone.0079000. eCollection 2013.

PMID:
24236082
[PubMed - in process]
Free PMC Article
7.

An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC).

Quinton C, Ellis PM.

Cancers (Basel). 2011 Sep 13;3(3):3506-24. doi: 10.3390/cancers3033506.

PMID:
24212966
[PubMed]
Free PMC Article
8.

The role of epidermal growth factor receptor mutations and epidermal growth factor receptor-tyrosine kinase inhibitors in the treatment of lung cancer.

Chang SC, Chang CY, Shih JY.

Cancers (Basel). 2011 Jun 10;3(2):2667-78. doi: 10.3390/cancers3022667.

PMID:
24212826
[PubMed]
Free PMC Article
9.

Emerging options for the management of non-small cell lung cancer.

Binder D, Hegenbarth K.

Clin Med Insights Oncol. 2013 Aug 21;7:221-34. doi: 10.4137/CMO.S10269. Review.

PMID:
24179413
[PubMed]
Free PMC Article
10.

Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.

Kathawala RJ, Wang YJ, Ashby CR Jr, Chen ZS.

Chin J Cancer. 2014 May;33(5):223-30. doi: 10.5732/cjc.013.10122. Epub 2013 Oct 9.

PMID:
24103790
[PubMed - in process]
Free PMC Article
11.

Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors.

Goldberg SB, Oxnard GR, Digumarthy S, Muzikansky A, Jackman DM, Lennes IT, Sequist LV.

Oncologist. 2013;18(11):1214-20. doi: 10.1634/theoncologist.2013-0168. Epub 2013 Sep 26.

PMID:
24072220
[PubMed - in process]
Free PMC Article
12.

Tobacco Smoking and Lung Cancer: Perception-changing facts.

Furrukh M.

Sultan Qaboos Univ Med J. 2013 Aug;13(3):345-58. Epub 2013 Jun 25.

PMID:
23984018
[PubMed]
Free PMC Article
13.

Vascular permeability and drug delivery in cancers.

Azzi S, Hebda JK, Gavard J.

Front Oncol. 2013 Aug 15;3:211. doi: 10.3389/fonc.2013.00211. eCollection 2013.

PMID:
23967403
[PubMed]
Free PMC Article
14.

Treatment outcomes in elderly with advanced-stage non-small cell lung cancer.

Tam TC, Ho JC, Wong MK, Wong WM, Wang JK, Lam JC, Lui MM, Lam WK, Ip MS, Lam DC.

Lung. 2013 Dec;191(6):645-54. doi: 10.1007/s00408-013-9498-9. Epub 2013 Aug 9.

PMID:
23929397
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC).

Furrukh M, Al-Moundhri M, Zahid KF, Kumar S, Burney I.

Sultan Qaboos Univ Med J. 2013 May;13(2):202-17. Epub 2013 May 9.

PMID:
23862025
[PubMed]
Free PMC Article
16.

Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?

Farhat FS, Houhou W.

Ther Adv Med Oncol. 2013 Jul;5(4):249-70. doi: 10.1177/1758834013492001.

PMID:
23858333
[PubMed]
Free PMC Article
17.

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland.

Kowalski DM, Krzakowski M, Ramlau R, Jaskiewicz P, Janowicz-┼╗ebrowska A.

Contemp Oncol (Pozn). 2012;16(2):170-5. doi: 10.5114/wo.2012.28798. Epub 2012 May 29.

PMID:
23788872
[PubMed]
Free PMC Article
18.

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.

Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S.

Onco Targets Ther. 2013 May 21;6:563-76. doi: 10.2147/OTT.S28155. Print 2013.

PMID:
23723712
[PubMed]
Free PMC Article
19.

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases.

Landis SH, Nordstrom BL, Sansbury LB, Shantakumar S, Laurent SA, Fraeman KH, Nelson JJ.

J Cancer Epidemiol. 2013;2013:358285. doi: 10.1155/2013/358285. Epub 2013 Apr 21.

PMID:
23710179
[PubMed]
Free PMC Article
20.

A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma.

Lv C, Ma Y, Feng Q, Fang F, Bai H, Zhao B, Yan S, Wu N, Zheng Q, Li S, Chen J, Wang J, Feng Y, Wang Y, Pei Y, Fang J, Yang Y.

World J Surg Oncol. 2013 Apr 26;11:96. doi: 10.1186/1477-7819-11-96.

PMID:
23621919
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk